Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds

Biological Chemistry

Volumn 390, Issue 11, 2009, Pages 1205-1212

  Cunha, Rodrigo L O R ^a,b   Gouvêa, Iuri E ^a   Feitosa, Geovana P V ^a   Alves, Márcio F M ^a   Brömme, Dieter ^c   Comasseto, João V ^d   Tersariol, Ivarne L S ^e   Juliano, Luiz ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

Cysteine protease; Inhibitors; Peptidase; Protease; Telluranes

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CYSTEINE; INORGANIC COMPOUND; ORGANIC COMPOUND; REDUCING AGENT; TELLURIUM DERIVATIVE;

ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; PRIORITY JOURNAL; STOICHIOMETRY;

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSINS; HUMANS; ORGANIC CHEMICALS; PROTEASE INHIBITORS; TELLURIUM;

EID: 70349789558     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.125     Document Type: Article

References (47)

1. Albeck, M., Tamari, T., and Sredni, B. (1989). Synthesis and properties of ammonium trichloro(dioxyethylene-O,O9) tellurate (AS-101), a new immunomodulating compound. Synthesis, 635-636.
2. Albeck, H.W., Weitman, H., Sredni, B., and Albeck, M. (1998). Tellurium compounds. Selective inhibitors of cysteine protease and model reaction with thiols. Inorg. Chem. 37, 1904-1912.
3. Alves, M.F., Puzer, L., Cotrin, S.S., Juliano, M.A., Juliano, L., Bromme, D., and Carmona, A.K. (2003). S3 to S39 subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates. Biochem. J. 373, 981-986.
4. Alves, F.M., Hirata, I.Y., Gouvea, I.E., Alves, M.F., Meldal, M., Bromme, D., Juliano, L., and Juliano, M.A. (2007). Controlled peptide solvation in portion-mixing libraries of FRET peptides: Improved specificity determination for Dengue 2 virus NS2B-NS3 protease and human cathepsin S. J. Comb. Chem. 9, 627-634.
5. Baici, A., Schenker, P., Wachter, M., and Ruedi, P. (2009). 3- Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods. Chem. Biodivers. 6, 261-282.
6. Barrett, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., and Hanada, K. (1982). L-trans-epoxysuccinyl- leucinamido(4- guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201, 189-198.
7. Bromme, D. and McGrath, M.F. (1996). High level expression and crystallization of recombinant human cathepsin S. Protein Sci. 5, 789-791.
8. Brubacher, L.J. and Glick, B.R. (1974). Inhibition of papain by N-ethylmaleimide. Biochemistry 13, 915-920.
9. Caracelli, I. (2004). Crystal structure of bis(benzyltriethylammonium) hexachlorotellurate(IV), wC7H7(C2H5)(3)Nx(2)(TeCl6). Z. Kristallogr. 219, 273-274.
10. Cesari, M.H., Puzer, L., Juliano, M.A., Carmona, A.K., and Juliano, L. (2002). Cathepsin B carboxypeptidase specificity analysis using internally quenched fluorescent peptides. Biochem. J. 368, 365-369.
11. Choe, Y., Leonetti, F., Greenbaum, D.C., Lecaille, F., Bogyo, M., Bromme, D., Ellman, J.A., and Craik, C.S. (2006). Substrate profiling of cysteine protease using a combinatorial peptide library identifies functionally unique specificities. J. Biol. Chem. 281, 12824-12832.
12. Chowdhury, S.F., Joseph, L., Kumar, S., Tulsidas, S.R., Bhat, S., Ziomek, E., Menard, R., Sivaraman, J., and Purisima, E.O. (2008). Exploring inhibitor binding at the S9 subsites of cathepsin L. J. Med. Chem. 51, 1361-1368.
13. Comasseto, J.V., Cunha, R.L.O.R., and Clososki, G.C. (2007). Tellurium. In: Comprehensive Organometallic Chemistry III, Vol.9, R.H. Crabtree and M.P. Mingos, eds. (Oxford, UK: Elsevier), pp. 587-648.
14. Cotrin, S.S., Puzer, L., Judice, W.A.S., Juliano, L., Carmona, A.K., and Juliano, M.A. (2004). Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides to define substrate specificity of carboxypeptidases: Assays with human cathepsin B. Anal. Biochem. 335, 244-252. (Pubitemid 39535189)
15. Cunha, R.L.O.R., Urano, M.E., Chagas, J.R., Almeida, P.C., Bincoletto, C., Tersariol, I.L.S., and Comasseto, J.V. (2005). Tellurium- based cysteine protease inhibitors: Evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem. Lett. 15, 755-760.
16. Cunha, R.L.O.R., Zukerman-Schpector, J., Caracelli, I., and Comasseto, J.V. (2006). Revisiting the addition reaction of TeCl4 to alkynes: The crystal structure and docking studies of 1-chloro-2-trichlorotelluro-3-phenyl-propen-2- ol. J. Organomet. Chem. 691, 4807-4815.
17. Ellman, G.L. (1959). Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70-77.
18. Gottlieb, H.E., Hoz, S., Elyashiv, I., and Albeck, M. (1994). Ligand-exchange processes in tetraalcoxytelluranes. Inorg. Chem. 33, 808-811.
19. Huang, C.K., Marhold, H., O'Brien, D.H., and Irgolic, K.J. (1994). The reaction of tellurium tetrachloride with acetone. Heteroatom Chem. 5, 463-467.
20. Jia, Z., Hasnain, S., Hirama, T., Lee, X., Mort, J.S., To, R., and Huber, C.P. (1995). Crystal structures of recombinant cathepsin B and a cathepsin B-inhibitor complex. Implications to structure-based drug design. J. Biol. Chem. 270, 5527-5533.
21. Johnson, L.A., Moon, K.E., and Eisenberg, M. (1988). Inactivation of chymotrypsin and human skin chymase: Kinetics of time-dependent inhibition in the presence of substrate. Biochim. Biophys. Acta 953, 269-279.
22. Kalechman, Y., Sredni, B., Weinstein, T., Freidkin, I., Tobar, A., Albeck, M., and Gafter, U. (2003). Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J. Am. Soc. Nephrol. 14, 620-630.
23. Lecaille, F., Kaleta, J., and Bromme, D. (2002). Human and parasitic papain-like cysteine proteases: Their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. 102, 4459-4488.
24. Lecaille, F., Bromme, D., and Lalmanach, G. (2008). Biochemical properties and regulation of cathepsin K activity. Biochimie 90, 208-226.
25. Linnevers, C.J., McGrath, M.E., Armstrong, R., Mistry, F.R., Barnes, M.G., Klaus, J.L., Palmer, J.T., Klatz, B.A., and Bromme, D. (1997). Expression of human cathepsin K in pichia pastoris and preliminary crystallographic studies of an inhibitor complex. Protein Sci. 6, 919-921.
26. Lopes-Ó tin, C. and Bond, J.S. (2008). Proteases: Multifunctional enzymes in life and disease. J. Biol. Chem. 283, 30433-30437.
27. McGrath, M.E. (1999). The lysosomal cysteine proteases. Annu. Rev. Biophys. Biomol. Struct. 28, 181-204.
28. Milne, J.B. (1991). Hexachlorotellurate(IV) hydrolysis equilibria in hydrochloric acid. Measurement by Raman and 125Te NMR spectroscopy and a reconsideration of earlier spectrophotometric results. Can. J. Chem. 69, 987-992.
29. Nagler, D.K., Storer, A.C., Portaro, F.C., Carmona, E., Juliano, L., and Menard, R. (1997). Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry 36, 12608-12615.
30. Nogueira, C.W., Zeni, G., and Rocha, J.B.T. (2004). Toxicology and pharmacology of selenium and tellurium compounds. Chem. Rev. 104, 6255-6285.
31. Okun, E., Arumugam, T.V., Tang, S.C., Gleichmann, M., Albeck, M., Sredni, B., and Mattson, M.P. (2007a). The organotellurium compound ammonium trichloro(dioxoethylene-O,O9) tellurate (AS101) enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J. Neurochem. 102, 1232-1241.
32. Okun, E., Dikshtein, Y., Carmely, A., Saida, H., Frei, G., Sela, B.A., Varshavsky, L., Ofir, A., Levy, E., Albeck, M., et al. (2007b). The organotellurium compound ammonium trichloro( dioxoethylene-O,O9)tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice. FEBS Lett. 274, 3159-3170.
33. Otto, H.-H. and Schirmeister, T. (1997). Cysteine proteases and their inhibitors. Chem. Rev. 97, 133-171.
34. Pauly, T.A., Sulea, T., Ammirati, M., Sivaraman, J., Danley, D.E., Griffor, M.C., Kamath, A.V., Wang, I.K., Laird, E.R., Seddon, A.P., et al. (2003). Specificity determinants of human cathepsin S revealed by crystal structures of complexes. Biochemistry 42, 3203-3213.
35. Persike, D.S., Cunha, R.L.O.R., Juliano, L., Silva, I.R., Rosim, F.E., Vignoli, T., Dona, F., Cavalheiro, E.A., and Fernandes, M.J. (2008). Protective effect of the organotelluroxetane RF- 07 in pilocarpine-induced status epilepticus. Neurobiol. Dis. 31, 120-126.
36. Pessoto, F.S., Faria, P.A., Cunha, R.L.O.R., Comasseto, J.V., Rodrigues, T., and Nantes, I.L. (2007). Organotellurane-promoted mitochondrial permeability transition concomitant with membrane lipid protection against oxidation. Chem. Res. Toxicol. 20, 1453-1461.
37. Schechter, I. and Berger, A. (1967). On the size of the active site of proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
38. Thompson, S.K., Halbert, S.M., Bossard, M.J., Tomaszek, T.A., Levy, M.A., Zhao, B., Smith, W.W., Abdel-Meguid, S.S., Janson, C.A., D'Alessio, K.J., et al. (1997). Design of potent and selective human cathepsin K inhibitors that span the active site. Proc. Natl. Acad. Sci. USA 94, 14249-14254.
39. Thurmond, R.L., Beavers, M.P., Cai, H., Meduna, S.P., Gustin, D.J., Sun, S., Almond, H.J., Karlsson, L., and Edwards, J.P. (2004). Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S. J. Med. Chem. 47, 4799-4801.
40. Turk, B. (2006). Targeting proteases: Successes, failures and future prospects. Nat. Rev. Drug Discov. 5, 785-799.
41. Vasiljeva, O., Reinheckel, T., Turk, D., Turk, V., and Turk, B. (2007). Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13, 385-401. (Pubitemid 46085285)
42. Yosef, S., Brodsky, M., Sredni, B., Albeck, A., and Albeck, M. (2007). Octa-O-bis-(R,R)-Tartarate Ditellurane (SAS) - a novel bioactive organotellurium(IV) compound: Synthesis, characterization, and protease inhibitory activity. ChemMedChem 2, 1601-1606.
43. Zeni, G., Chieffi, A., Cunha, R.L.O.R., Zukerman-Schpector, J., Stefani, H.A., and Comasseto, J.V. (1999). Addition reaction of p-methoxyphenyltellurium trichloride to alkynes. Organometallics 18, 803-806.
44. Zukerman-Schpector, J., Camillo, R.L., Comasseto, J.V., Cunha, R.L.O.R., and Caracelli, I. (1999a). Benzyltriethylammonium 2,2,2,4-tetrachloro-2,5- dihydro-1,2-l5-oxa-tellurole. Acta Cryst. C56, 897-898.
45. Zukerman-Schpector, J., Camillo, R.L., Comasseto, J.V., Cunha, R. L.O.R., Chieffi, A., Zeni, G., and Caracelli, I. (1999b). Dichloro w(E)-2-chloro-1-(2- hydroxyprop-2-yl)vinylx(4-methoxyphenyltellurium( IV). Acta Crystallogr. C55, 1339-1341.
46. Zukerman-Schpector, J., Haiduc, I., Dabdoub, M.J., Biazotto, J.C., Braga, A.L., Dornelles, L., and Caracelli, I. (2002a). Dichloro-bis(2-chloro-2-phenyl- vinyl)Te(IV) and dibromo-bis (2-bromo-2-phenyl-vinyl)Te(IV): Supramolecular self-assembly through different pi-aryl interactions. Z. Kristallogr. 217, 609-613.
47. Zukerman-Schpector, J., Haiduc, I., Camillo, R.L., Comasseto, J.V., Cunha, R.L.O.R., and Jorge, A. (2002b). Supramolecular self-assembly through tellurium center halogen secondary bonds: A hexagonal grid of Te2Cl2 and Te6Cl6 rings in the solid state structure of 1,1,3-trichloro-2,4,5,6-tetrahydro-1H-1 l4- benzowbxtellurophene. Can. J. Chem. 80, 1530-1537.